<document id="DDI-DrugBank.d706">
    <sentence id="DDI-DrugBank.d706.s0" text="Catecholamine-depleting drugs (e.g., reserpine) may have an additive effect when given with beta-blocking agents. ">
        <entity charOffset="37-45" id="DDI-DrugBank.d706.s0.e0" text="reserpine" type="drug" />
        <entity charOffset="92-111" id="DDI-DrugBank.d706.s0.e1" text="beta-blocking agents" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d706.s0.e0" e2="DDI-DrugBank.d706.s0.e1" id="DDI-DrugBank.d706.s0.p0" type="effect" />
    </sentence>
    <sentence id="DDI-DrugBank.d706.s1" text="Patients treated with extended release metoprolol succinate plus a catecholamine depletor should therefore be closely observed for evidence of hypotension or marked bradycardia, which may produce vertigo, syncope, or postural hypotension.">
        <entity charOffset="39-58" id="DDI-DrugBank.d706.s1.e0" text="metoprolol succinate" type="drug" />
    </sentence>
</document>